Abstract:FLASH radiotherapy (RT) is a novel technique in which the ultrahigh dose rate (UHDR) (≥40 Gy/s) is delivered to the entire treatment volume. Recent outcomes of in vivo studies show that the UHDR RT has the potential to spare normal tissue without sacrificing tumor control. There is a growing interest in the application of FLASH RT, and the ultrahigh dose irradiation delivery has been achieved by a few experimental and modified linear accelerators. The underlying mechanism of FLASH effect is yet to be fully und… Show more
“…Investigations have shown the FLASH effect with x-rays in the kilovolt range [ 6 – 9 ] and efforts to achieve the FLASH effect with megavoltage x-rays [ 6 , 10 ]. Regardless, an attractive and readily available option to deliver a FLASH beam is cyclotron-based protons, specifically pencil beam scanning (PBS), because PBS can be better controlled in terms of position and intensity [ 11 ].…”
Shoot-through proton FLASH radiation therapy has been proposed where the highest energy is extracted from a cyclotron to maximize the dose rate (DR). Although our proton pencil beam scanning system can deliver 250 MeV (the highest energy), this energy is not used clinically, and as such, 250 MeV has yet to be characterized during clinical commissioning. We aim to characterize the 250-MeV proton beam from the Varian ProBeam system for FLASH and assess the usability of the clinical monitoring ionization chamber (MIC) for FLASH use.
We measured the following data for beam commissioning: integral depth dose curve, spot sigma, and absolute dose. To evaluate the MIC, we measured output as a function of beam current. To characterize a 250 MeV FLASH beam, we measured (1) the central axis DR as a function of current and spot spacing and arrangement, (2) for a fixed spot spacing, the maximum field size that achieves FLASH DR (ie, > 40 Gy/s), and (3) DR reproducibility. All FLASH DR measurements were performed using an ion chamber for the absolute dose, and irradiation times were obtained from log files. We verified dose measurements using EBT-XD films and irradiation times using a fast, pixelated spectral detector.
R90 and R80 from integral depth dose were 37.58 and 37.69 cm, and spot sigma at the isocenter were σx = 3.336 and σy = 3.332 mm, respectively. The absolute dose output was measured as 0.343 Gy*mm2/MU for the commissioning conditions. Output was stable for beam currents up to 15 nA and gradually increased to 12-fold for 115 nA. Dose and DR depended on beam current, spot spacing, and arrangement and could be reproduced with 6.4% and 4.2% variations, respectively.
Although FLASH was achieved and the largest field size that delivers FLASH DR was determined as 35 × 35 mm2, the current MIC has DR dependence, and users should measure dose and DR independently each time for their FLASH applications.
“…Investigations have shown the FLASH effect with x-rays in the kilovolt range [ 6 – 9 ] and efforts to achieve the FLASH effect with megavoltage x-rays [ 6 , 10 ]. Regardless, an attractive and readily available option to deliver a FLASH beam is cyclotron-based protons, specifically pencil beam scanning (PBS), because PBS can be better controlled in terms of position and intensity [ 11 ].…”
Shoot-through proton FLASH radiation therapy has been proposed where the highest energy is extracted from a cyclotron to maximize the dose rate (DR). Although our proton pencil beam scanning system can deliver 250 MeV (the highest energy), this energy is not used clinically, and as such, 250 MeV has yet to be characterized during clinical commissioning. We aim to characterize the 250-MeV proton beam from the Varian ProBeam system for FLASH and assess the usability of the clinical monitoring ionization chamber (MIC) for FLASH use.
We measured the following data for beam commissioning: integral depth dose curve, spot sigma, and absolute dose. To evaluate the MIC, we measured output as a function of beam current. To characterize a 250 MeV FLASH beam, we measured (1) the central axis DR as a function of current and spot spacing and arrangement, (2) for a fixed spot spacing, the maximum field size that achieves FLASH DR (ie, > 40 Gy/s), and (3) DR reproducibility. All FLASH DR measurements were performed using an ion chamber for the absolute dose, and irradiation times were obtained from log files. We verified dose measurements using EBT-XD films and irradiation times using a fast, pixelated spectral detector.
R90 and R80 from integral depth dose were 37.58 and 37.69 cm, and spot sigma at the isocenter were σx = 3.336 and σy = 3.332 mm, respectively. The absolute dose output was measured as 0.343 Gy*mm2/MU for the commissioning conditions. Output was stable for beam currents up to 15 nA and gradually increased to 12-fold for 115 nA. Dose and DR depended on beam current, spot spacing, and arrangement and could be reproduced with 6.4% and 4.2% variations, respectively.
Although FLASH was achieved and the largest field size that delivers FLASH DR was determined as 35 × 35 mm2, the current MIC has DR dependence, and users should measure dose and DR independently each time for their FLASH applications.
“…Note that DL models were trained with phantom data, while the SECT stoichiometric method and DECT empirical data were optimized for clinical use with both phantom and human tissue, which might lead to a worse performance than DL models on anthropomorphic phantoms mass density and RSP estimation. Improving the mass density estimation accuracy and reducing proton range uncertainty and margin may also help the proton ultra-high dose rate therapy which are actively investigated in research field [24].…”
Proton therapy requires highly accurate dose calculation for treatment planning to ensure the doses delivered to the tumor precisely. The accuracy of mass density estimation dominates the uncertainty in proton dose calculation. This work proposed a fully connected neural network (FCNN) based framework to estimate mass density from single-energy compute tomography. The FCNN was design as 9 hidden layers and 150 hidden units and nonlinear activation function. A CIRS 062M electron density phantom was used to train FCNN, and CIRS M701 and M702 was used to evaluate the performance of models. For M701, FCNN has mean absolute percentage errors of mass density at 0.39%,0.92%,0.68%,1.57,0.92% over brain, spinal cord, soft tissue, lung, and bone. For M702, the mean absolute percentage errors of mass density estimation by FCNN are 0.89%,1.09%,0.70%,1.52% and 3.19%, respectively.
“…The maximum number of spots to be removed each time was limited as N M prior to the spot reduction process. In each iteration, the N R least weighted spots were firstly removed from the planning, and the corresponding weights, w R , were excluded from w. Then, w were updated by the optimal weights, w * , acquired from solving the optimization problem formulated in (5). At last, the number of spots, N s , of weights ≥ w min was obtained and the minimum value between N R and N M was assigned to N R .…”
“…[1][2][3][4][5] Normal tissue sparing by the FLASH effect has been observed in several in vivo small animal studies using electron, photon, and proton beams. [1][2][3][4][5][6][7][8] The radiobiological mechanisms contributing to the FLASH effect have not yet been fully clarified, however, oxygen depletion and reactive oxygen species production are currently the most supported hypothesis. 9,10 The FLASH treatment of a first patient with T-cell cutaneous lymphoma using an electron beam has been shown to achieve promising outcomes both on normal skin and the tumor.…”
Background: Ultra-high dose rate (FLASH) proton planning with only transmission beams (TBs) has limitations in normal tissue sparing. The single-energy spread-out Bragg peaks (SESOBPs) of the FLASH dose rate have been demonstrated feasible for proton FLASH planning. Purpose: To investigate the feasibility of combining TBs and SESOBPs for proton FLASH treatment. Methods: A hybrid inverse optimization method was developed to combine the TBs and SESOBPs (TB-SESOBP) for FLASH planning. The SESOBPs were generated field-by-field from spreading out the BPs by pre-designed general bar ridge filters (RFs) and placed at the central target by range shifters (RSs) to obtain a uniform dose within the target.The SESOBPs and TBs were fully placed field-by-field allowing automatic spot selection and weighting in the optimization process. A spot reduction strategy was conducted in the optimization process to push up the minimum MU/spot assuring the plan deliverability at beam current of 165 nA. The TB-SESOBP plans were validated in comparison with the TB only (TB-only) plans and the plans with the combination of TBs and BPs (TB-BP plans) regarding 3D dose and dose rate (dose-averaged dose rate) distributions for five lung cases. The FLASH dose rate coverage (V 40Gy/s ) was evaluated in the structure volume receiving > 10% of the prescription dose. Results: Compared to the TB-only plans, the mean spinal cord D 1.2cc drastically reduced by 41% (P < 0.05), the mean lung V 7Gy and V 7.4 Gy moderately reduced by up to 17% (P < 0.05), and the target dose homogeneity slightly increased in the TB-SESOBP plans. Comparable dose homogeneity was achieved in both TB-SESOBP and TB-BP plans. Besides, prominent improvements were achieved in lung sparing for the cases of relatively large targets by the TB-SESOBP plans compared to the TB-BP plans. The targets and the skin were fully covered with the FLASH dose rate in all three plans. For the OARs, V 40Gy/s = 100% was achieved by the TB-only plans while V 40Gy/s > 85% was obtained by the other two plans.
Conclusion:We have demonstrated that the hybrid TB-SESOBP planning was feasible to achieve FLASH dose rate for proton therapy. With pre-designed general bar RFs,the hybrid TB-SESOBP planning could be implemented for proton adaptive FLASH radiotherapy. As an alternative FLASH planning approach to TB-only planning, the hybrid TB-SESOBP planning has great potential in dosimetrically improving OAR sparing while maintaining high target dose homogeneity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.